Oral administration of C-SBLNs can reduce leukocyte infiltration, oxidative stress and proinflammatory cytokines (TNF-α), restore colon structure in DSS-induced colitis mice (Sharma et al., 2019). This evidence concerns the gene TNF and colitis.